COVID-19 Research Paper Volume 13, Issue 7 pp 9253—9264

Beneficial effect of Arbidol in the management of COVID-19 infection

Dynamic profile of laboratory and immunological parameters in COVID-19 patients treated with Arbidol. (A) Lymphocyte count. (B) hs-CRP. (C) LDH. (D) D-dimer. (E) IL-6. (F) IL-10.

Figure 3. Dynamic profile of laboratory and immunological parameters in COVID-19 patients treated with Arbidol. (A) Lymphocyte count. (B) hs-CRP. (C) LDH. (D) D-dimer. (E) IL-6. (F) IL-10.